Air elimination assemblies are described herein. An air elimination assembly for eliminating air from a flow of infusate includes a housing and a hydrophobic filter. The housing defines an infusate flow path having an inlet and an outlet, and an air flow path in fluid communication with the infusate flow path and disposed between the inlet and the outlet of the infusate flow path. The hydrophobic filter is disposed in fluid communication with the air flow path, wherein the hydrophobic filter is configured to permit air from the flow of infusate through a hydrophobic filter media and prevent the flow of infusate through the hydrophobic filter media.

Hydrophilic flat-sheet membrane based on a hydrophobic first polymer from the group consisting of aromatic sulfone polymers and a hydrophilic second polymer, wherein the membrane has a thickness in the range between 30 and 200 μm, a first and a second surface and a supporting layer having a three-dimensional sponge-like network structure, wherein the supporting layer has a first cover layer on the side thereof facing the first surface and a second cover layer on the side thereof facing the second surface, which cover layers are formed integrally with the supporting layer, and wherein the first and second surfaces have approximately oval or circular openings which penetrate the first and second cover layers, respectively, and are connected to the supporting layer, wherein the average diameter of the openings in the surfaces differ by a factor of less than 2, wherein the three-dimensional network structure of the supporting layer is made up of thick branches and a continuous pore system, and the predominant proportion of the branches have a diameter of at least 0.5 μm at the thinnest point thereof and wherein the pores in the supporting layer are larger than the openings in the surfaces.

An implantable system includes cells that produce and release a therapeutic agent, or agents, to a host in need. The system can include cells capable of eluting therapeutic agents in response to changing physiological conditions within a host. The system may comprise naked cells, encapsulated cells, or a mixture of non-encapsulating and encapsulated cells. The system may also comprise cells, and/or cell groups, of different origins. The implantable device may be placed intra-vascular, within bone marrow, within soft tissue, in the peritoneal cavity, or intra-hepatic, etc. The system can be comprised of a stent, or like devices. Such stents and like devices may optionally include port(s), catheter(s), and containment envelope systems for holding the above cells.

A filtration device includes: a housing that defines a liquid flow path; and a filtration sheet that separates the liquid flow path into a flow path upstream side and a flow path downstream side. The housing includes: a first housing member and a second housing member that sandwich the filtration sheet, and a joining member that joins the first housing member and the second housing member in a state in which the filtration sheet is sandwiched between the first housing member and the second housing member. A gap is located between the first housing member and the second housing at a position outward of an outer edge of the filtration sheet. The joining member seals the gap between the first housing member and the second housing member at the position outward of the outer edge of the filtration sheet.

A channel for a medicinal liquid is formed in a filter-integrated medicine transfer device according to an embodiment of the present disclosure. The filter-integrated medicine transfer device includes: a housing having an air passage that diverges from a medicinal liquid channel and is connected to outside; at least one hydrophobic air-passing filter disposed in the housing and disposed at a boundary between the air passage and the medicinal liquid channel; and at least one medicine transfer pipe disposed in the housing and having a capillary channel constituting a portion of the medicinal liquid channel.

An air filter device for medicinal liquid injection in which a medicinal liquid channel is formed includes: a housing having an air passage that diverges from the medicinal liquid channel and is connected to outside; a hydrophilic boundary filter disposed in the medicinal liquid channel and dividing the medicinal liquid channel into a first channel at an upstream side and a second channel at a downstream side; and a hydrophobic air-passing filter disposed at a boundary between the air passage and the first channel.

A method of manufacturing a check valve may include forming an upper housing as cylindrical body with (i) an internal surface including an upstream internal surface and a downstream internal surface having a projection and (ii) an external surface, forming a T-shaped filter member and mounting the T-shaped filter member in the internal surface of the upper housing. The method may further include forming a lower housing with a support portion at a central portion thereof, mounting a flexible valve member on the support portion, and coupling the upper housing with T-shaped filter member mounted therein onto the lower housing with flexible valve member mounted therein such that the T-shaped filter member is disposed upstream of the flexible valve member.

Embodiments of devices and methods to maintain preservative concentration in a medication delivered using a medical device are provided. A barrier layer can be used to prevent migration of preservatives. A vent can be used to allow release of preservatives prior to delivery to the patient. An absorbent element can be used to maintain preservative concentration at a desired level. A filter can be used to capture particulates from the medication prior to delivery to a patient.

A method of manufacturing a check valve may include forming an upper housing as cylindrical body with (i) an internal surface including an upstream internal surface and a downstream internal surface having a projection and (ii) an external surface, forming a T-shaped filter member and mounting the T-shaped filter member in the internal surface of the upper housing. The method may further include forming a lower housing with a support portion at a central portion thereof, mounting a flexible valve member on the support portion, and coupling the upper housing with T-shaped filter member mounted therein onto the lower housing with flexible valve member mounted therein such that the T-shaped filter member is disposed upstream of the flexible valve member.

The present invention discloses a sterile PRP separation kit that has compartmentalized container having a cover that allows for a stage-specific exposure of sterile components of the sterile PRP separation kit housed within stage-specific compartments to a non-sterile environment commensurate with a specific stage of operation of a separation process of PRP. The sterile PRP separation kit includes a PRP tube with segregated portals for injection of blood into the PRP tube, aspiration of PRP from the PRP tube, and for maintaining an interior pressure of the PRP tube at equilibrium with ambient pressure during both injection and aspiration.